AAAAAA

   
Results: 1-25 |
Results: 25
The stressed synovium
Authors: Schett, G Tohidast-Akrad, M Steiner, G Smolen, J
Citation: G. Schett et al., The stressed synovium, ARTHRITIS R, 3(2), 2001, pp. 80-86
Decreased serum erythropoietin and its relation to anti-erythropoietin antibodies in anaemia of systemic lupus erythematosus
Authors: Schett, G Firbas, U Fureder, W Hiesberger, H Winkler, S Wachauer, D Koller, M Kapiotis, S Smolen, J
Citation: G. Schett et al., Decreased serum erythropoietin and its relation to anti-erythropoietin antibodies in anaemia of systemic lupus erythematosus, RHEUMATOLOG, 40(4), 2001, pp. 424-431
Minimal clinically important difference module: Summary, recommendations, and research agenda
Authors: Wells, G Anderson, J Beaton, D Bellamy, N Boers, M Bombardier, C Breedveld, F Carr, A Cranney, A Dougados, M Felson, D Kirwan, J Schiff, M Shea, B Simon, L Smolen, J Strand, V Tugwell, P van Riel, P Welch, VA
Citation: G. Wells et al., Minimal clinically important difference module: Summary, recommendations, and research agenda, J RHEUMATOL, 28(2), 2001, pp. 452-454
Monoclonal antibody therapy
Authors: Park, JW Smolen, J
Citation: Jw. Park et J. Smolen, Monoclonal antibody therapy, ADV PROTEIN, 56, 2001, pp. 369-421
Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischernia/reperfusion
Authors: Lindsey, M Wedin, K Brown, MD Keller, C Evans, AJ Smolen, J Burns, AR Rossen, RD Michael, L Entman, M
Citation: M. Lindsey et al., Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischernia/reperfusion, CIRCULATION, 103(17), 2001, pp. 2181-2187
Role of tumor necrosis factor alpha and potential benefit of tumor necrosis factor blockade treatment in systemic lupus erythematosus: comment on theeditorial by Pisetsky
Authors: Aringer, M Steiner, G Graninger, W Smolen, J
Citation: M. Aringer et al., Role of tumor necrosis factor alpha and potential benefit of tumor necrosis factor blockade treatment in systemic lupus erythematosus: comment on theeditorial by Pisetsky, ARTH RHEUM, 44(7), 2001, pp. 1721-1722
Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice
Authors: Schett, G Hayer, S Tohidast-Akrad, M Schmid, BJ Lang, S Turk, B Kainberger, F Haralambous, S Kollias, G Newby, AC Xu, QB Steiner, G Smolen, J
Citation: G. Schett et al., Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice, ARTH RHEUM, 44(12), 2001, pp. 2888-2898
Autoantibody reactivity in a case of Schnitzler's syndrome: Evidence for aTh1-like response and detection of IgG2 anti-Fc epsilon RIa antibodies
Authors: Sperr, WR Natter, S Baghestanian, M Smolen, J Wolff, K Binder, BR Muller, MR Lechner, K Valenta, R Valent, P
Citation: Wr. Sperr et al., Autoantibody reactivity in a case of Schnitzler's syndrome: Evidence for aTh1-like response and detection of IgG2 anti-Fc epsilon RIa antibodies, INT A AL IM, 122(4), 2000, pp. 279-286
Endpoints: consensus recommendations from OMERACT IV
Authors: Strand, V Gladman, D Isenberg, D Petri, M Smolen, J Tugwell, P
Citation: V. Strand et al., Endpoints: consensus recommendations from OMERACT IV, LUPUS, 9(5), 2000, pp. 322-327
HLA class II alleles associations of anticardiolipin and anti-beta(2)GPI antibodies in a large series of European patients with systemic lupus erythematosus
Authors: Galeazzi, M Sebastiani, GD Tincani, A Piette, JC Allegri, F Morozzi, G Bellisai, F Scorza, R Ferrara, GB Carcassi, C Font, J Passiu, G Smolen, J Papasteriades, C Houssiau, F Nebro, AF Garrido, ED Jedryka-Goral, A Marcolongo, R
Citation: M. Galeazzi et al., HLA class II alleles associations of anticardiolipin and anti-beta(2)GPI antibodies in a large series of European patients with systemic lupus erythematosus, LUPUS, 9(1), 2000, pp. 47-55
Rheumatoid arthritis of the craniocervical region: assessment and characterization of inflammatory soft tissue proliferations with unenhanced and contrast-enhanced CT
Authors: Czerny, C Grampp, S Henk, CB Neuhold, A Stiskal, M Smolen, J
Citation: C. Czerny et al., Rheumatoid arthritis of the craniocervical region: assessment and characterization of inflammatory soft tissue proliferations with unenhanced and contrast-enhanced CT, EUR RADIOL, 10(9), 2000, pp. 1416-1422
Cardiovascular autonomic function, autoantibodies, and esophageal motor activity in patients with systemic sclerosis and mixed connective tissue disease
Authors: Stacher, G Merio, R Budka, C Schneider, C Smolen, J Tappeiner, G
Citation: G. Stacher et al., Cardiovascular autonomic function, autoantibodies, and esophageal motor activity in patients with systemic sclerosis and mixed connective tissue disease, J RHEUMATOL, 27(3), 2000, pp. 692-697
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations
Authors: Galeazzi, M Annunziata, P Sebastiani, GD Bellisai, F Campanella, V Ferrara, GB Font, J Houssiau, F Passiu, G Garrido, ED Fernandez-Nebro, A Bracci, L Scorza, R Puddu, P Jedryka-Goral, A Smolen, J Tincani, A Carcassi, C Morozzi, G Marcolongo, R
Citation: M. Galeazzi et al., Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations, J RHEUMATOL, 27(1), 2000, pp. 135-141
Fas-activation inhibits activation of heat shock factor (hsF)-1 and expression of heat shock protein (hsp) 70
Authors: Schett, G Steiner, CW Winkler, S Graninger, W Smolen, J Xu, Q Steiner, G
Citation: G. Schett et al., Fas-activation inhibits activation of heat shock factor (hsF)-1 and expression of heat shock protein (hsp) 70, ACT MED AUS, 27(3), 2000, pp. 94-98
The lupus erythematosus cell phenomenon - Comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera
Authors: Schett, G Rubin, RL Steiner, G Hiesberger, H Muller, S Smolen, J
Citation: G. Schett et al., The lupus erythematosus cell phenomenon - Comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera, ARTH RHEUM, 43(2), 2000, pp. 420-428
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2
Authors: Brooks, P Emery, P Evans, JF Fenner, H Hawkey, CJ Patrono, C Smolen, J Breeveld, F Day, R Dougados, M Ehrich, EW Gijon-Banos, J Kvien, TK Van Rijswijk, MH Warner, T Zeidler, H
Citation: P. Brooks et al., Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2, RHEUMATOLOG, 38(8), 1999, pp. 779-788
Activation of Fas inhibits heat-induced activation of HSF1 and up-regulation of hsp70
Authors: Schett, G Steiner, CW Groger, M Winkler, S Graninger, W Smolen, J Xu, QB Steiner, G
Citation: G. Schett et al., Activation of Fas inhibits heat-induced activation of HSF1 and up-regulation of hsp70, FASEB J, 13(8), 1999, pp. 833-842
Association of 16/6 and SA1 anti-DNA idiotypes with antibodies and clinical manifestations in a large cohort of SLE patients (vol 16, pg 717, 1998)
Authors: Galeazzi, M Bellisai, F Sebastiani, GD Morozzi, G Marcolongo, R Cervera, R Garrido, ED Nebro, AF Houssiau, F Goral, AJ Mathieu, A Papasteriades, C Piette, JC Scorza, R Smolen, J
Citation: M. Galeazzi et al., Association of 16/6 and SA1 anti-DNA idiotypes with antibodies and clinical manifestations in a large cohort of SLE patients (vol 16, pg 717, 1998), CLIN EXP RH, 17(1), 1999, pp. 141-141
Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies (vol 16, pg 541, 1998)
Authors: Galeazzi, M Morozzi, G Sebastiani, GD Bellisai, F Marcolongo, R Cervera, R Garrido, ED Nebro, AF Houssiau, F Goral, AJ Mathieu, A Papasteriades, C Piette, JC Scorza, R Smolen, J
Citation: M. Galeazzi et al., Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies (vol 16, pg 541, 1998), CLIN EXP RH, 17(1), 1999, pp. 141-141
Outcome measures to be used in clinical trials in systemic lupus erythematosus
Authors: Strand, V Gladman, D Isenberg, D Petri, M Smolen, J Tugwell, P
Citation: V. Strand et al., Outcome measures to be used in clinical trials in systemic lupus erythematosus, J RHEUMATOL, 26(2), 1999, pp. 490-497
Anticardiolipin and anti-beta(2)GPI antibodies in a large series of European patients with systemic lupus erythematosus - Prevalence and clinical associations
Authors: Sebastiani, GD Galeazzi, M Tincani, A Piette, JC Font, J Allegri, F Mathieu, A Smolen, J Garrido, ED Fernandez-Nebro, A Jedryka-Goral, A Papasteriades, C Morozzi, G Bellisai, F De Pita, O Marcolongo, R
Citation: Gd. Sebastiani et al., Anticardiolipin and anti-beta(2)GPI antibodies in a large series of European patients with systemic lupus erythematosus - Prevalence and clinical associations, SC J RHEUM, 28(6), 1999, pp. 344-351
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
Authors: Maini, R St Clair, EW Breedveld, F Furst, D Kalden, J Weisman, M Smolen, J Emery, P Harriman, G Feldmann, M Lipsky, P
Citation: R. Maini et al., Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial, LANCET, 354(9194), 1999, pp. 1932-1939
Issues in rheumatoid arthritis
Authors: Emery, P Smolen, J
Citation: P. Emery et J. Smolen, Issues in rheumatoid arthritis, LANCET, 353(9159), 1999, pp. 1186-1186
Expression of adhesion molecules on synovial fluid and peripheral blood monocytes in patients with inflammatory joint disease and osteoarthritis
Authors: Koller, M Aringer, M Kiener, H Erlacher, L Machold, K Eberl, G Studnicka-Benke, A Graninger, W Smolen, J
Citation: M. Koller et al., Expression of adhesion molecules on synovial fluid and peripheral blood monocytes in patients with inflammatory joint disease and osteoarthritis, ANN RHEUM D, 58(11), 1999, pp. 709-712
Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients
Authors: Wiesinger, GF Quittan, M Graninger, M Seeber, A Ebenbichler, G Sturm, B Kerschan, K Smolen, J Graninger, W
Citation: Gf. Wiesinger et al., Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients, BR J RHEUM, 37(12), 1998, pp. 1338-1342
Risultati: 1-25 |